(Funded by the National Science Foundation and the U.S. Department of Energy)
Scientists from Washington State University and the U.S. Department of Energy’s Lawrence Berkeley National Laboratory have discovered a way to make ions move more than ten times faster in mixed organic ion-electronic conductors. These conductors combine the advantages of the ion signaling used by many biological systems with the electron signaling used by computers. The new development speeds up ion movement in these conductors by using molecules that attract and concentrate ions into a separate nanochannel creating a type of tiny “ion superhighway.” These types of conductors hold a lot of potential because they allow movement of both ions and electrons at once, which is critical for battery charging and energy storage.

(Funded by the National Science Foundation)
Researchers from the University of Illinois at Urbana-Champaign have discovered a new type of nanoparticle, palladium hydride, which contains palladium and hydrogen. Palladium hydride nanoparticles are typically structured symmetrically, looking like a cube with palladium atoms posted at each corner and centered on all six cubic faces. In contrast, the new nanoparticle’s structure is presumably the least symmetrical of all crystal systems. To create this unusual nanoparticle, the researchers added electrons to a solution containing palladium ions and water, and the electrons’ negative charge pulled positive hydrogen ions from the water molecules, allowing the hydrogen ions to bond with the palladium ions.

(Funded by the National Science Foundation)
Physicists at the Massachusetts Institute of Technology (MIT) have taken a key step toward solving the puzzle of what leads electrons to split into fractions of themselves. The new work is an effort to make sense of a discovery that was reported earlier this year by other physicists at MIT, who found that electrons appear to exhibit “fractional charge” in pentalayer graphene – a configuration of five graphene layers that are stacked atop a similarly structured sheet of boron nitride. Through calculations of quantum mechanical interactions, the scientists showed that the electrons form a sort of crystal structure, the properties of which are ideal for fractions of electrons to emerge. “This crystal has a whole set of unusual properties that are different from ordinary crystals, and leads to many fascinating questions for future research,” said Senthil Todadri, the scientist who led the new study.

(Funded by the National Institutes of Health and the National Science Foundation)
Researchers at the University of Massachusetts Amherst and the University of Massachusetts-Chan Medical School in Springfield, MA, have invented a new, sprayable delivery system for psoriasis medication that can be applied easily and locally to psoriasis lesions. The delivery system makes use of nanoparticles that contain psoriasis drugs, and these nanoparticles act like a trojan horse – the immune cells do not recognize the nanoparticles as a threat, but the medication they carry disrupts the overactive immune response. The researchers designed and tested nanoparticles in different shapes: rods, ellipses and spheres and discovered that nanorods inhibited 3.8 times more inflammation due to psoriasis than nanoellipses and 4.5 times more than nanospheres.

(Funded by the National Institutes of Health)
Researchers from Case Western Reserve University, the University of Virginia, Cleveland Clinic, the University of Maryland School of Medicine, University Hospitals Cleveland Medical Center, the Louis Stokes Veterans Affairs Medical Center (Cleveland, OH), and CVPath Institute, Inc. (Gaithersburg, MD) have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heart attack. The researchers identified an inflammation-reducing molecule, called itaconate, and developed a new lipid nanoparticle-based treatment that allows itaconate to accumulate in plaque and bone marrow, where it reduces inflammation. “We’ve found that itaconate is crucial to the diet’s ability to stabilize plaques and reduce inflammation, which has been a mystery until now,” said Andrei Maiseyeu, one of the scientists involved in this study. “This discovery marks a major leap forward in the understanding of how diet-induced plaque resolution occurs at a molecular level.”